胸腺瘤外科治疗

目的 对96例胸腺瘤进行临床分析,了解胸腺瘤手术与分期、预后的关系。方法 总结96例胸腺瘤患者,按Masaoka分期法进行分期。分析不同分期胸腺瘤与生存率之间关系。结果完整手术切除83例(86.5％),姑息性切除9例(9.4％),探查活检4例(4.2％),死亡1例(1.04％)。5年、10年生存率Ⅰ期为91.4％、84.5％,Ⅱ期为70.6％、52.9％,Ⅲ期为50.0％、28.6％,Ⅳa期为14.3％、0。结论 胸腺瘤治疗应尽可能完整切除肿瘤及部分周围组织,以达到手术彻底切除。Masao-ka分期是主要预后因素。

Report on surgical treatment of thymoma in 96 patients

Objective To analyze the characteristics of operation and the prognosis in 96 patients with thymoma.Methods Data of 96 patients operated for thymoma were collected.The distribution according to Masao-ka staging showed stage I in 58 patients,stage II in 17 cases,stage III in 14 cases,and stage IVa in 7 cases.The relation between stage and survival rate was analyzed. Results Of the 96 patients 83 underwent complete resection,9 underwent palliative operation,and 4 were biopsied only. One patient died of operation.The 5- and 10- year survial rates were 91.4% ,84.5% for stage I ,70.6% ,52.9% for stage II ,50.0% ,28.6% for stage III, 14.3% ,0 for stage IVa,respectively. Conclusion The best treatment for thymoma is to resect it as completely as possible. Masaoka's clinical staging is an important prognostic factor.